New long-term treatment data confirms consistent benefit and safety profile of Pradaxa® beyond 6 years
19 November 2013 | By Boehringer Ingelheim
Pradaxa® is the only novel oral anticoagulant with more than 6 years of long-term data supporting its beneficial role for stroke prevention...